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Background:  
Multiple sclerosis (MS) is an incurable, unpredictable but typically progressive 
neurological condition. Within 15 years of diagnosis, approximately 50% of people 
are unable to walk unaided, and over time an estimated 25% depend on a 
wheelchair. Those who are more severely impaired spend much of their day sitting, 
often with limited ability to change position. In response, secondary complications 
can occur including: muscle wasting and weakness, pain, reduced skin integrity, 
spasms, stiffness, constipation, and associated psychosocial problems such as 
depression. Effective self-management strategies, which can be implemented 
relatively easily and cheaply are needed to improve mobility and reduce sedentary 
behaviour. This is challenging, particularly in the latter stages of disease. Regular 
supported standing is one potential option.  
 
Methods/Design: SUMS is a pragmatic multi-centre randomised controlled trial 
evaluating use of Oswestry standing frames with blinded outcome assessment and 
full economic evaluation. Participants are randomly allocated (1:1) to either a home-
based, self-management standing programme (with advice and support) along with 
their usual care or to usual care alone. The intervention group participants are asked 
to stand for 30 minutes three times weekly over 20 weeks. Participants are followed-
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up at 20 and 36 weeks post baseline. The primary clinical outcome is motor function 
(Amended Motor Club Assessment) and primary economic endpoint is quality-
adjusted life years. Secondary outcomes include measures of explanatory physical 
impairments, key clinical outcomes, and health–related quality of life. An embedded 
qualitative component explores participant’s and carer’s experiences of the standing 
programme. 
 
Discussion: This is the first powered multi-centre trial to assess the clinical and cost 
effectiveness of a home based standing frame programme for people severely 
impaired by MS. If demonstrated to be effective this evidence will be used to develop 
recommendations for a health service delivery model which could be implemented 
across the UK. 
 
Trial Registration: ISRCTN69614598 
